¼¼°èÀÇ ³ì³»Àå ¼ö¼ú ±â±â ½ÃÀå
Glaucoma Surgery Devices
»óǰÄÚµå : 1768525
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 279 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,222,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,666,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ³ì³»Àå ¼ö¼ú ±â±â ½ÃÀåÀº 2030³â±îÁö 83¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 26¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ³ì³»Àå ¼ö¼ú ±â±â ½ÃÀåÀº 2024-2030³â¿¡ CAGR 21.0%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 83¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ±âÁ¸ÇüÀº CAGR 20.8%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 31¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÃÖ¼Òħ½À(Minimal Invasive) ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 23.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 6¾ï 6,960¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 26.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³ì³»Àå ¼ö¼ú ±â±â ½ÃÀåÀº 2024³â¿¡ 6¾ï 6,960¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 22¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 26.6%ÀÔ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, °¢°¢ ºÐ¼® ±â°£ Áß 15.8%¿Í 18.5%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 17.4%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³ì³»Àå ¼ö¼ú ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³ì³»Àå ¼ö¼ú Àåºñ´Â ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

³ì³»Àå ¼ö¼ú Àåºñ´Â Àü ¼¼°è ½Ç¸íÀÇ ÁÖ¿ä ¿øÀÎÀÎ ³ì³»Àå Ä¡·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ±â±âµéÀº ¾à¹° Ä¡·á³ª ´ú ħ½ÀÀûÀÎ Ä¡·á°¡ È¿°ú°¡ ¾ø´Â ȯÀÚÀÇ ¾È¾Ð(IOP)À» ³·Ãß±â À§ÇØ °í¾ÈµÇ¾ú½À´Ï´Ù. ¾È°úÇÐÀÇ ¹ßÀü°ú ÇÔ²² ³ì³»Àå ¼ö¼úÀº ±âÁ¸ÀÇ Ä§½ÀÀûÀÎ ¹æ¹ý¿¡¼­ ȸº¹ ½Ã°£À» ´ÜÃàÇϰí ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â ÃÖ¼Òħ½À³ì³»Àå¼ö¼ú(MIGS)·Î ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ¼ÇÆ®, ½ºÅÙÆ®, ·¹ÀÌÀú¸¦ ÀÌ¿ëÇÑ ½Ã½ºÅÛ µîÀÇ Àåºñ°¡ ü¾×À» ¹èÃâÇÏ°í ¾È¾ÐÀ» ³·Ãç ½Ã½Å°æÀÇ Ãß°¡ ¼Õ»óÀ» ¿¹¹æÇϱâ À§ÇØ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ°¡ ÁøÇàµÇ°í ³ì³»Àå¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ È¿°úÀûÀÎ ¼ö¼úÀû Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä´Â Áõ°¡ÇÏ´Â Ãß¼¼ÀÔ´Ï´Ù.

³ì³»Àå ¼ö¼ú ÀåºñÀÇ ÁÖ¿ä ºÎ¹®°ú ¿ëµµ´Â?

³ì³»Àå ¼ö¼ú Àåºñ ½ÃÀåÀº ¹è¼ö ÀÓÇöõÆ®, ½ºÅÙÆ®, ·¹ÀÌÀú Àåºñ µî Á¦Ç° À¯Çüº°·Î ºÐ·ùµË´Ï´Ù. ¹æ¼ö·Î ¼ÇÆ®¿Í °°Àº ¹è¼ö ÀÓÇöõÆ®´Â ÁøÇ༺ ³ì³»Àå ȯÀÚ¿¡°Ô »ç¿ëµÇ¾î ü¾×ÀÇ »õ·Î¿î ¹èÃâ °æ·Î¸¦ ¸¸µì´Ï´Ù. ¾È±¸³» »ðÀԵǴ ÀÛÀº ½ºÅÙÆ®¸¦ Æ÷ÇÔÇÑ MIGS Àåºñ´Â ħ½À¼ºÀÌ ³·°í À§Çèµµ°¡ ³·±â ¶§¹®¿¡ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¼±ÅÃÀû ·¹ÀÌÀú ÇØ¸éü ¼ºÇü¼ú(SLT) ¹× ¾Æ¸£°ï ·¹ÀÌÀú ÇØ¸éü ¼ºÇü¼ú(ALT)À» Æ÷ÇÔÇÑ ·¹ÀÌÀú ½Ã½ºÅÛÀº ü¾× À¯ÃâÀ» °³¼±ÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ¾È°ú Ŭ¸®´Ð°ú °°Àº ÃÖÁ¾»ç¿ëÀÚ¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù. ºÏ¹Ì¿Í À¯·´Àº ÷´ÜÈ­µÈ ÀÇ·á ÀÎÇÁ¶ó¿Í ³ôÀº ³ì³»Àå À¯º´·ü·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÇ·á Á¢±Ù¼º Çâ»óÀ¸·Î ÀÎÇØ ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ³ì³»Àå ¼ö¼ú Àåºñ¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

±â¼úÀÇ ¹ßÀüÀº ³ì³»Àå ¼ö¼ú Àåºñ, ƯÈ÷ ÃÖ¼Òħ½ÀÀû ¼Ö·ç¼Ç °³¹ß¿¡ Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖÀ¸¸ç, MIGS Àåºñ´Â Çõ½ÅÀÇ ÃÖÀü¼±¿¡ ¼­¼­ ±âÁ¸ ¼ö¼úÀÌ ÀûÇÕÇÏÁö ¾ÊÀº ³ì³»Àå ȯÀڵ鿡°Ô º¸´Ù ¾ÈÀüÇϰí È¿°úÀûÀÎ ¿É¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ Àåºñ´Â ¾È±¸ ¿Ü»óÀ» ÁÙÀ̰í ȸº¹À» °¡¼ÓÈ­ÇϹǷΠ¾È°ú ÀÇ»ç¿Í ȯÀÚµé »çÀÌ¿¡¼­ Á¡Á¡ ´õ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ·¹ÀÌÀú ±â¼úÀÇ ¹ßÀüÀº ³ì³»Àå ¼ö¼úÀÇ Á¤È®¼º°ú È¿°ú¸¦ ³ôÀ̰í ÀÖÀ¸¸ç, ¾È¾ÐÀ» ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â ½º¸¶Æ® ÀÓÇöõÆ®µµ ¼ö¼ú ÈÄ °ü¸®¸¦ Çõ½ÅÀûÀ¸·Î º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É°ú ·Îº¿ °øÇÐÀÌ ÀÌ ºÐ¾ß¿¡ ÁøÀÔÇϱ⠽ÃÀÛÇϸ鼭 Á¤¹Ð ¼ö¼ú°ú °á°ú ¿¹Ãø¿¡ »õ·Î¿î °¡´É¼ºÀ» Á¦°øÇÕ´Ï´Ù.

³ì³»Àå ¼ö¼ú Àåºñ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

³ì³»Àå ¼ö¼ú Àåºñ ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ ¿äÀÎ, ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ÀÇ ³ì³»Àå À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ³ì³»Àå ¼ö¼úÀÌ º¸´Ù ¾ÈÀüÇϰí Ä£¼÷ÇØÁö¸é¼­ º¸±ÞÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ³ì³»Àå Á¶±â Áø´Ü ¹× Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ȯÀÚµéÀÌ º¸´Ù È¿°úÀûÀÎ ÇØ°áÃ¥À» ã°Ô µÇ¸é¼­ ¼ö¼ú Àåºñ ½ÃÀåÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼±Áø±¹ÀÇ ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÌ ½ÃÀå °³¹ßÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±°ú ÷´Ü ¾È°ú Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ ³ì³»Àå ¼ö¼ú Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

¼ö¼ú ¹æ¹ý(±âÁ¸Çü, Àúħ½À, ·¹ÀÌÀú); ÃÖÁ¾»ç¿ëÀÚ(º´¿ø, ¾È°ú Ŭ¸®´Ð, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Glaucoma Surgery Devices Market to Reach US$8.3 Billion by 2030

The global market for Glaucoma Surgery Devices estimated at US$2.6 Billion in the year 2024, is expected to reach US$8.3 Billion by 2030, growing at a CAGR of 21.0% over the analysis period 2024-2030. Traditional, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Minimal Invasive segment is estimated at 23.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$669.6 Million While China is Forecast to Grow at 26.6% CAGR

The Glaucoma Surgery Devices market in the U.S. is estimated at US$669.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.8% and 18.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.4% CAGR.

Global Glaucoma Surgery Devices Market - Key Trends and Drivers Summarized

How Are Glaucoma Surgery Devices Evolving to Meet Rising Demand?

Glaucoma surgery devices play a crucial role in the treatment of glaucoma, a leading cause of blindness worldwide. These devices are designed to reduce intraocular pressure (IOP) in patients where medications or less invasive treatments have failed. With advancements in ophthalmology, glaucoma surgery has evolved from traditional, invasive procedures to minimally invasive glaucoma surgeries (MIGS), which reduce recovery times and improve patient outcomes. Devices such as shunts, stents, and laser-based systems are used to drain fluid and lower IOP, preventing further damage to the optic nerve. As the aging population grows and awareness of glaucoma increases, the demand for effective surgical treatments is on the rise.

What Are the Major Segments and Applications of Glaucoma Surgery Devices?

The glaucoma surgery devices market is segmented by product type, including drainage implants, stents, and laser devices. Drainage implants, such as aqueous shunts, are used in patients with advanced glaucoma to create new drainage pathways for fluid. MIGS devices, including tiny stents that are implanted in the eye, are gaining popularity due to their less invasive nature and lower risk profiles. Laser systems, which include selective laser trabeculoplasty (SLT) and argon laser trabeculoplasty (ALT), are used to improve fluid outflow. The market is also segmented by end-users, such as hospitals, ambulatory surgical centers, and ophthalmic clinics. North America and Europe dominate the market due to advanced healthcare infrastructure and high glaucoma prevalence, while Asia-Pacific is witnessing rapid growth as healthcare access improves.

How Are Technological Innovations Impacting Glaucoma Surgery Devices?

Technological advancements are revolutionizing glaucoma surgery devices, particularly in the development of minimally invasive solutions. MIGS devices are at the forefront of innovation, offering safer and more effective options for glaucoma patients who are not candidates for traditional surgery. These devices reduce trauma to the eye and speed up recovery times, making them increasingly popular among ophthalmologists and patients alike. Advances in laser technologies are also enhancing the precision and effectiveness of glaucoma surgeries, while smart implants that monitor intraocular pressure in real-time are poised to transform post-surgical care. Furthermore, artificial intelligence and robotics are beginning to enter the field, offering new possibilities for precision surgeries and outcome prediction.

What Factors Are Driving the Growth in the Glaucoma Surgery Devices Market?

The growth in the glaucoma surgery devices market is driven by several factors, including the rising prevalence of glaucoma, particularly among the aging population. Technological advancements in minimally invasive surgical techniques are making glaucoma surgery safer and more accessible, driving increased adoption. Growing awareness about early diagnosis and treatment of glaucoma is expanding the market for surgical devices as patients seek more effective solutions. Additionally, increased healthcare expenditure and favorable reimbursement policies in developed regions are supporting market growth. In emerging markets, improved healthcare infrastructure and access to advanced ophthalmic treatments are further fueling the demand for glaucoma surgery devices.

SCOPE OF STUDY:

The report analyzes the Glaucoma Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Surgery Method (Traditional, Minimal Invasive, Laser); End-Use (Hospitals, Ophthalmic Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â